Breaking News, Collaborations & Alliances

ValGenesis Tapped by Japanese Multinational Biopharma Company to Implement ICH Q14 Framework

Will implement a structured framework covering the ICH Q14 guideline on Analytical Method Development, specifically for PAT.

Author Image

By: Charlie Sternberg

Associate Editor

ValGenesis Inc., an expert in enterprise validation lifecycle management systems (VLMS), has announced that a Japanese multinational biopharmaceutical company selected ValGenesis iRisk for implementing the ICH Q14 framework on Process Analytical Technology (PAT) analytical methods across its global manufacturing sites.   Already aware of ValGenesis’ experience helping customers implement PAT tools, the top 20 biopharmaceuticals company approached ValGenesis to implement a structured fram...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters